Winton Group
ACHN

Winton Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Winton Group’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-134,700
Closed -$812K – 1622
2019
Q4 		$812K Buy
+134,700
New +$780K 0.01% 1115

Winton Group's ACHN Position: Q1 2020 in Review

Winton Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 134,700 shares — an estimated $812K sold.

Winton Group first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $812K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Winton Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Winton Group sold 134,700 Achillion Pharmaceuticals shares in Q1 2020, an estimated $812K.
  • Winton Group first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Winton Group's Achillion Pharmaceuticals position peaked at $812K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Winton Group's 13F filing for Q1 2020, filed 11 May 2020.